APR 24, 2018 9:11 PM PDT

New Treatment Option for the Non-Cancerous Form of the Prostate

WRITTEN BY: Nouran Amin

A new therapy known as ‘prostate artery embolization’ or PAE seeks to treat the non-cancerous enlargement of the prostate, or benign prostatic hyperplasia (BPH), which is a common condition seen in older men.

Prostate artery embolization blocks some of the blood supply from reaching the prostate using tiny synthetic beads, ultimately treating troubling tissue. The treatment is non-invasive and may spare men surgery and side-effects including impotence. “Prostate artery embolization gives men with BPH a treatment option that is less invasive than other therapies and allows them to return to their normal lives sooner.”

Having an enlarged prostate is seen in about a third of men over the age of 50, which can make it difficult for them to pass urine. Currently, some drug treatments and surgical interventions can help however, other treatment options should be offered. In fact, roughly 20 research centers in the UK have already placed patients on this treatment has part of a clinical trial.

A consultant interventional radiologist at the University Hospital Southampton, Dr Nigel Hacking, explains that, "It is a particularly good option for men who are not yet ready to undergo more invasive prostate surgery. Maintaining sexual function and fertility is one of its main strengths” says lead author of the PAE study, Joao Martins Pisco, “this minimally invasive treatment is successful in the long term and should always be presented to patients who are exploring options to resolve their BPH.”

The prostate gland is a crucial part of the male reproductive system, and it works to produce the fluid to carry and nurture sperm. With BAE, if left untreated, it may interfere with the bladder function, causing affected men to go use the toilet to pass urine. If BPH is not treated at all it can cause urine infections and/or damage to the bladder and kidneys.

Sources: BBC News, Urology Health

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 27, 2019
Drug Discovery & Development
NOV 27, 2019
Vaccine Causes More Polio Cases than Wild Virus
The World Health Organization (WHO) has confirmed that 11 new cases of polio in five African countries including Nigeria, Congo and Angola were caused by a...
DEC 20, 2019
Drug Discovery & Development
DEC 20, 2019
Drug Repurposing May Provide Hope for Deadly Childhood Seizure Disorder
The life-threatening and treatment-resistant seizure disorder among children known as the ‘Dravet Syndrome’ may soon have new safe and effectiv...
JAN 06, 2020
Drug Discovery & Development
JAN 06, 2020
Designing Drugs To Fight off C. Diff Infections
A study published by PNAS explains breakthrough research around designing drugs that target C. diff bacterial infections that result in 15,000 deaths in th...
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
FEB 10, 2020
Drug Discovery & Development
FEB 10, 2020
Drug Prevents Coronavirus in Monkeys
An antiviral drug successfully prevented Middle East respiratory syndrome coronavirus (MERS-CoV) in infected rhesus macaques. The drug, Remdesivir, was adm...
Loading Comments...